Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Depreciation and Depletion (2016 - 2025)

China Pharma Holdings filings provide 10 years of Depreciation and Depletion readings, the most recent being $59927.0 for Q4 2025.

  • On a quarterly basis, Depreciation and Depletion fell 80.53% to $59927.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $553107.0, a 73.34% decrease, with the full-year FY2025 number at $652026.0, down 69.96% from a year prior.
  • Depreciation and Depletion hit $59927.0 in Q4 2025 for China Pharma Holdings, down from $158076.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $966956.0 in Q3 2021 to a low of $59927.0 in Q4 2025.
  • Median Depreciation and Depletion over the past 5 years was $635149.0 (2023), compared with a mean of $542053.0.
  • Biggest five-year swings in Depreciation and Depletion: surged 45.54% in 2021 and later crashed 80.53% in 2025.
  • China Pharma Holdings' Depreciation and Depletion stood at $701100.0 in 2021, then fell by 10.03% to $630781.0 in 2022, then rose by 0.44% to $633577.0 in 2023, then crashed by 51.43% to $307741.0 in 2024, then plummeted by 80.53% to $59927.0 in 2025.
  • The last three reported values for Depreciation and Depletion were $59927.0 (Q4 2025), $158076.0 (Q3 2025), and $163503.0 (Q2 2025) per Business Quant data.